Pre-emptive Patenting: Securing Market Exclusion and Freedom of Operation (OECD Science, Technology and Industry Working Paper 2009/8)

This paper investigates the characteristics, functioning and incidence of pre-emptive patenting, defined as patent filings whose main effect is to hamper the grant of other patents.

OECD Science, Technology and Industry Scoreboard 2009 focuses on innovation

What impact has the crisis had on innovation and spending on research and development? How can innovation help to solve environmental and social threats? The OECD Science, Technology and Industry Scoreboard 2009 provides the data and analysis to answer these questions.

OECD Science, Technology and Industry Scoreboard 2009: United States Highlights

This country note, extracted from the STI Scoreboard 2009, explores recent developments in matters relating to innovation, science, technology and globalisation in the United States.

Related Documents

• OECD Science, Technology and Industry Scoreboard 2007

Guidelines for a Harmonised Statistical Approach to Biotechnology Research and Development in the Government and Higher Education Sectors

The aim of these guidelines is to propose a harmonised approach for the collection and analysis of biotechnology research and development (R&D) statistics in the government and higher education sectors.

Innovation in the Software Sector

This book throws a spotlight on innovation across the software universe, setting out key issues and highlighting policy perspectives. It spans research and development, invention, production, distribution and use of software in the market.

UNITAR/OECD/ IOMC Awareness-Raising Workshop for Developing and Transition Countries on Nanotechnology/Manufactured Nanomaterials

Following the recommendation from the ICCM2 (SAICM), OECD and UNITAR agreed to hold a series of “IOMC/OECD/UNITAR Awareness-Raising Workshops for Developing and Transition Countries on Nanotechnology /Manufactured Nanomaterials” in conjunction with SAICM regional meetings during 2009/2010

Innovation in Firms: A Microeconomic Perspective

This book presents the main results of the first large-scale effort to exploit firm-level data from innovation surveys across 20 countries in an internationally harmonised way, with a view to addressing common analytical questions.

Related Documents

• OECD Innovation Microdata Project
• The OECD Innovation Strategy

Pharmacogenetics: Opportunities and Challenges for Health Innovation

This book reviews how the emergence of pharmacogenetics will impact the efficiency of pharmaceutical R&D and improve healthcare decision making and clinical care. It discusses what policies need to change in order for the public to reap the benefits from advances in diagnostic genetic testin

Related Documents

• Workshop on Pharmacogenetics: The Intersections between Innovation, Regulation and Health Delivery
• Genetics and Genomics
• Innovation in Pharmaceutical Biotechnology: Comparing National Innovation Systems at the Sectoral Level
• The OECD Innovation Strategy

Guidelines for Human Biobanks and Genetic Research Databases (HBGRDs)

The ability to effectively use these vast amounts of knowledge will depend in part on the bringing together of different strands of information, data and biological materials within human biobanks and genetic research databases (HBGRDs).

Related Documents

• Creation and Governance of Human Genetic Research Databases
• Genetics and Genomics

Guidance for the use of OECD Database on Research into the Safety of Manufactured Nanomaterials

The Database on Research into the Safety of Manufactured Nanomaterials (the Database) develops a global resource, which identifies research projects that address human health and environmental safety issues associated with manufactured nanomaterials.